News AN2 Therapeutics, Inc.

Equities

ANTX

US0373261058

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
2.47 ^USD	+1.23%		-2.76%	-87.95%

Apr. 03	North American Morning Briefing : Powell Awaited -2-	DJ
Apr. 02	JMP Securities Upgrades AN2 Therapeutics to Market Outperform From Market Perform	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Powell Awaited -2-	Apr. 03	DJ
JMP Securities Upgrades AN2 Therapeutics to Market Outperform From Market Perform	Apr. 02	MT
North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights	Mar. 28	BU
AN2 Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
AN2 Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results	Mar. 25	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX	Mar. 11	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX	Mar. 03	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX	Feb. 24	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. - ANTX	Feb. 15	PR
North American Morning Briefing :Stock Futures -2-	Feb. 14	DJ
Leerink Partners Downgrades AN2 Therapeutics to Market Perform From Outperform, Adjusts PT to $7 From $23	Feb. 13	MT
AN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase 2/3 Pivotal Clinical Trial Evaluating Epetraborole for Treatment-Refractory Mycobacterium Avium Complex Lung Disease	Feb. 13	AQ
North American Morning Briefing : Stocks Seen -2-	Feb. 13	DJ
US Equity Markets Close Mixed Monday Ahead of Inflation Data for January	Feb. 12	MT
Sector Update: Health Care Stocks Mixed Late Afternoon	Feb. 12	MT
Sector Update: Health Care	Feb. 12	MT
Top Midday Decliners	Feb. 12	MT
Oppenheimer Downgrades AN2 Therapeutics to Market Perform From Outperform	Feb. 12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AN2 Therapeutics, Inc.

Equities

ANTX

US0373261058

Summary

Filters